{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T21:46:21Z","timestamp":1648935981966},"reference-count":21,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>TEM-154, identified in Portugal in 2004, associated the substitutions observed in the extended-spectrum \u03b2-lactamase (ESBL) TEM-12 and in the inhibitor-resistant penicillinase (IRT) TEM-33. This enzyme exhibited hydrolytic activity against ceftazidime and a low level of resistance to clavulanic acid. Surprisingly, the substitution Met69Leu enhanced the catalytic efficiency of oxyimino \u03b2-lactams conferred by the substitution Arg164Ser. Its discovery confirms the dissemination of the complex mutant group of TEM enzymes in European countries.<\/jats:p>","DOI":"10.1128\/aac.01359-10","type":"journal-article","created":{"date-parts":[[2010,12,21]],"date-time":"2010-12-21T06:06:50Z","timestamp":1292911610000},"page":"1262-1265","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of the Novel CMT Enzyme TEM-154"],"prefix":"10.1128","volume":"55","author":[{"given":"Fre\u0301de\u0301ric","family":"Robin","sequence":"first","affiliation":[{"name":"CHU Clermont-Ferrand, Centre de Biologie, Laboratoire de bacte\u0301riologie clinique, Clermont-Ferrand, F-63003 France"},{"name":"Clermont, Universite\u0301, Universite\u0301 d'Auvergne, JE2526 Evolution des bacte\u0301ries pathoge\u0300nes et susceptibilite\u0301 ge\u0301ne\u0301tique de l'ho\u0302te, Clermont-Ferrand, F-63001 France"},{"name":"INRA, USC2018, Clermont-Ferrand, France"}]},{"given":"Julien","family":"Delmas","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, Centre de Biologie, Laboratoire de bacte\u0301riologie clinique, Clermont-Ferrand, F-63003 France"},{"name":"Clermont, Universite\u0301, Universite\u0301 d'Auvergne, JE2526 Evolution des bacte\u0301ries pathoge\u0300nes et susceptibilite\u0301 ge\u0301ne\u0301tique de l'ho\u0302te, Clermont-Ferrand, F-63001 France"},{"name":"INRA, USC2018, Clermont-Ferrand, France"}]},{"given":"Elisabete","family":"Machado","sequence":"additional","affiliation":[{"name":"REQUIMTE, Faculdade de Farma\u0301cia, Universidade do Porto, Porto, Portugal"},{"name":"CEBIMED, Laborato\u0301rio de Microbiologia, Faculdade de Cie\u0302ncias da Sau\u0301de, Universidade Fernando Pessoa, Porto, Portugal"}]},{"given":"Bernadette","family":"Bouchon","sequence":"additional","affiliation":[{"name":"Clermont, Universite\u0301, Universite\u0301 d'Auvergne, INSERM UMR990 Imagerie Mole\u0301culaire et The\u0301rapie Vectorise\u0301e, Clermont-Ferrand, F-63001 France"}]},{"given":"Lui\u0301sa","family":"Peixe","sequence":"additional","affiliation":[{"name":"REQUIMTE, Faculdade de Farma\u0301cia, Universidade do Porto, Porto, Portugal"}]},{"given":"Richard","family":"Bonnet","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, Centre de Biologie, Laboratoire de bacte\u0301riologie clinique, Clermont-Ferrand, F-63003 France"},{"name":"Clermont, Universite\u0301, Universite\u0301 d'Auvergne, JE2526 Evolution des bacte\u0301ries pathoge\u0300nes et susceptibilite\u0301 ge\u0301ne\u0301tique de l'ho\u0302te, Clermont-Ferrand, F-63001 France"},{"name":"INRA, USC2018, Clermont-Ferrand, France"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.11.3061-3068.2000"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.4.447"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2452"},{"key":"e_1_3_2_6_2","unstructured":"Performance standards for antimicrobial susceptibility testing; 19th informational supplement (M100-S19). 2009"},{"key":"e_1_3_2_7_2","unstructured":"Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. 2009. Communiqu\u00e9 2009. Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie Paris France. http:\/\/www.sfm.asso.fr\/publi\/general.php?pa=1."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1499-1505.2000"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.145.3.1365-1373.1981"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(73)80154-1"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.11.3232-3234.2000"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm381"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00916-5"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3591-3594.2001"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.5.626"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.12.4528-4531.2004"},{"key":"e_1_3_2_18_2","first-page":"2043","volume":"50","year":"2006","unstructured":"Robin, F., et al. 2006. CMT-type \u03b2-lactamase TEM-125, an emerging problem for extended spectrum \u03b2-lactamase detection. Antimicrob. Agents Chemother. 50:2043-2048.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00614-07"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.11.4443-4447.2005"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01058-06"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.6.1322"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01359-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01359-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:18:13Z","timestamp":1645485493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01359-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1128\/AAC.01359-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.01359-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"2010-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-12-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-02-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}